Abstract
Background:
Part of the heterogeneity of the obesity phenotype may originate from genetic differences between obese individuals that may influence energy expenditure (EE).
Objective:
To examine if common single-nucleotide polymorphisms (SNPs) in genes related to obesity-associated phenotypes are associated with postabsorptive resting energy expenditure (REE) and postprandial REE in obese individuals.
Design and methods:
Postabsorptive REE and 3-h postprandial REE (liquid test meal containing 95% fat, energy content 50% of estimated REE) were measured in 743 obese individuals from eight clinical centres in seven European countries. The analysis assessed the association of genotypes of 44 SNPs in 28 obesity-related candidate genes with postabsorptive REE and postprandial REE taking into consideration the influence of body composition, habitual physical activity, insulin sensitivity, circulating thermogenic hormones and metabolites.
Results:
After adjustment for fat-free mass (FFM), age, sex and research centre, SNPs in CART, GAD2, PCSK1, PPARG3, HSD11B1 and LIPC were significantly associated with postabsorptive REE. SNPs in GAD2, HSD11B1 and LIPC remained significantly associated with postabsorptive REE after further adjustment for fat mass (FM). SNPs in CART, PPARG2 and IGF2 were significantly associated with postprandial REE after similar adjustments. These associations with postprandial REE remained significant after further adjustment for FM. FTO, UCP2 and UCP3 variants were not associated with postabsorptive or postprandial REE.
Conclusions:
Several gene polymorphisms associated with obesity-related phenotypes but not FTO and UCP variants may be responsible for some of the inter-individual variability in postabsorptive REE and fat-induced thermogenesis unaccounted for by FFM, FM, age and sex. The association between FTO and obesity that has been reported earlier may not be mediated directly through modulation of EE in obese individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bogardus C, Lillioja S, Ravussin E, Abbott W, Zawadzki JK, Young A et al. Familial dependence of the resting metabolic rate. N Engl J Med 1986; 315: 96–100.
Astrup A, Buemann B, Christensen NJ, Madsen J, Gluud C, Bennett P et al. The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. J Clin Endocrinol Metab 1992; 74: 279–286.
Blaak EE, Hul G, Verdich C, Stich V, Martinez JA, Petersen M et al. Impaired fat-induced thermogenesis in obese subjects: the NUGENOB study. Obesity (Silver Spring) 2007; 15: 653–663.
Fontaine E, Savard R, Tremblay A, Despres JP, Poehlman E, Bouchard C . Resting metabolic rate in monozygotic and dizygotic twins. Acta Genet Med Gemellol (Roma) 1985; 34: 41–47.
Clement K, Sørensen TIA (eds). Obesity: Genomics and Postgenomics 1st edn. Informa Healthcare, UK, 2007. pp 1–600.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889–894.
Major GC, Doucet E, Trayhurn P, Astrup A, Tremblay A . Clinical significance of adaptive thermogenesis. Int J Obes (Lond) 2007; 31: 204–212.
Petersen M, Taylor MA, Saris WH, Verdich C, Toubro S, Macdonald I et al. Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content. Int J Obes (Lond) 2006; 30: 552–560.
Baecke JA, Burema J, Frijters JE . A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936–942.
Tehard B, Saris WH, Astrup A, Martinez JA, Taylor MA, Barbe P et al. Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study. Med Sci Sports Exerc 2005; 37: 1535–1541.
Weir JB . New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1–9.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Sørensen TIA, Boutin P, Taylor MA, Larsen LH, Verdich C, Petersen L et al. Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets. PLoS Clin Trials 2006; 1: e12.
Bell CG, Walley AJ, Froguel P . The genetics of human obesity. Nat Rev Genet 2005; 6: 221–234.
Blomeke B, Shields PG . Laboratory methods for the determination of genetic polymorphisms in humans. IARC Sci Publ 1999; 133–147.
Raymond M, Rousset F . GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Heredity 1995; 86: 248–249.
Zhao JH, Lissarrague S, Essioux L, Sham PC . GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics 2002; 18: 1694–1695.
Boesgaard TW, Castella SI, Andersen G, Albrechtsen A, Sparso T, Borch-Johnsen K et al. A −243A-->G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects. Diabet Med 2007; 24: 702–706.
Boutin P, Dina C, Vasseur F, Dubois S, Corset L, Seron K et al. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol 2003; 1: E68.
Guerardel A, Barat-Houari M, Vasseur F, Dina C, Vatin V, Clement K et al. Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet 2005; 6: 19.
Swarbrick MM, Waldenmaier B, Pennacchio LA, Lind DL, Cavazos MM, Geller F et al. Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biol 2005; 3: e315.
Vrang N, Tang-Christensen M, Larsen PJ, Kristensen P . Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res 1999; 818: 499–509.
Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998; 393: 72–76.
Van Vugt DA, Lujan ME, Froats M, Krzemien A, Couceyro PR, Reid RL . Effect of fasting on cocaine-amphetamine-regulated transcript, neuropeptide Y, and leptin receptor expression in the non-human primate hypothalamus. Neuroendocrinology 2006; 84: 83–93.
Draper N, Echwald SM, Lavery GG, Walker EA, Fraser R, Davies E et al. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab 2002; 87: 4984–4990.
Rosado EL, Bressan J, Martins MF, Cecon PR, Martinez JA . Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite 2007; 49: 635–643.
Landsberg L . Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens A 1990; 12: 817–830.
Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD . Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 2001; 10: 1491–1501.
Gu D, O'Dell SD, Chen XH, Miller GJ, Day IN . Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11. Hum Genet 2002; 110: 173–181.
Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007; 318: 1469–1472.
Berentzen T, Kring SI, Holst C, Zimmermann E, Jess T, Hansen T et al. Lack of association of fatness-related FTO gene variants with energy expenditure or physical activity. J Clin Endocrinol Metab 2008; 93: 2904–2908.
Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320–323.
Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155–2163.
Maestrini S, Podesta F, Di Blasio AM, Savia G, Brunani A, Tagliaferri A et al. Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest 2003; 26: 985–990.
Yanovski JA, Diament AL, Sovik KN, Nguyen TT, Li H, Sebring NG et al. Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children. Am J Clin Nutr 2000; 71: 1405–1420.
Fang QC, Jia WP, Yang M, Bao YQ, Chen L, Zhang R et al. Effect of polymorphism of uncoupling protein 3 gene −55 (C>T) on the resting energy expenditure, total body fat and regional body fat in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 485–488.
Halsall DJ, Luan J, Saker P, Huxtable, S Farooqi IS, Keogh J et al. Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population. Int J Obes Relat Metab Disord 2001; 25: 472–477.
Lanouette CM, Giacobino JP, Perusse L, Lacaille M, Yvon C, Chagnon M et al. Association between uncoupling protein 3 gene and obesity-related phenotypes in the Quebec Family Study. Mol Med 2001; 7: 433–441.
Schrauwen P, Hoeks J, Schaart G, Kornips E, Binas B, Van De Vusse GJ et al. Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J 2003; 17: 2272–2274.
Cancello R, Tounian A, Poitou C, Clement K . Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 2004; 30: 215–227.
Goyenechea E, Dolores Parra M, Martinez JA . Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br J Nutr 2006; 96: 965–972.
Acknowledgements
We acknowledge Claus Holst for his valuable contribution regarding the analytical strategy used in this study. This study was supported by the European Community (Contract no. QLK1-CT-2000-00618). The funding organization had no role in the preparation of the manuscript.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Goossens, G., Petersen, L., Blaak, E. et al. Several obesity- and nutrient-related gene polymorphisms but not FTO and UCP variants modulate postabsorptive resting energy expenditure and fat-induced thermogenesis in obese individuals: the NUGENOB Study. Int J Obes 33, 669–679 (2009). https://doi.org/10.1038/ijo.2009.59
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2009.59
Keywords
This article is cited by
-
Endoplasmic reticulum-associated degradation of the mouse PC1/3-N222D hypomorph and human PCSK1 mutations contributes to obesity
International Journal of Obesity (2016)
-
The ‘Fat Mass and Obesity Related’ (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance
Current Obesity Reports (2015)
-
Lifestyle factors modify obesity risk linked to PPARG2 and FTO variants in an elderly population: a cross-sectional analysis in the SUN Project
Genes & Nutrition (2013)
-
The biology of FTO: from nucleic acid demethylase to amino acid sensor
Diabetologia (2013)
-
Allelic clustering and ancestry-dependent frequencies of rs6232, rs6234, and rs6235 PCSK1 SNPs in a Northern Ontario population sample
Journal of Community Genetics (2012)